Exam 2 - 2022 Flashcards
(40 cards)
When maintained at certain registered locations, which of the following products must be stored in a safe?
a. oxycodone
b. lamotrigine
c. thiafentanil
d. phenobarbital
e. methadone
c. thiafentanil
On April 5, 2022, a prescriber saw a patient and wanted to issue a tramadol prescription. The provider has a general idea of the information that must be listed, but they are unsure what information is required on a prescription for this product. They provide you with a list of information they believe they should add to a prescription. Which item is not required on a controlled substance prescription?
a. MG1234563
b. April 5, 2022
c. May cause drowsiness.
d. tramadol 50mg
e. Take one tablet by mouth every night at bedtime.
c. May cause drowsiness.
Select all of the following products that can be ordered using the single-sheet version of the DEA 222.
a. Lamictal
b. pentobarbital
c. ketamine
d. codeine/acetaminophen
e. Vyvanse
b, e
A pharmacist receives a prescription for a controlled substance and notes several red flags with the prescription. What is the most appropriate choice in this situation?
a. Refuse to dispense the medication and write notes on the prescription warning other pharmacists that it is fraudulent.
b. Call the provider to attempt to resolve the red flags identified.
c. Notify the police that the patient has forged a prescription.
d. Tell the patient the medication is out of stock, so they take it to a different pharmacy.
b. Call the provider to attempt to resolve the red flags identified.
On April 1, 2022, a patient requests you transfer all of their prescriptions to your pharmacy chain, YNWA Pharmacy. YNWA Pharmacy is a chain without a shared database. They have prescriptions across multiple pharmacies and pharmacy chains. Which prescription can you transfer to your location today?
a. Librium, at City Pharmacy, a chain with a shared database, written February 18, 2022, filled twice with three refills remaining, transferred previously from another City Pharmacy.
b. Lomotil, at a different YNWA Pharmacy, written September 29, 2021, filled once with one refill remaining, transferred previously from City Pharmacy.
c. Phentermine, at City Pharmacy, a chain with a shared database, written December 5, 2022, filled three times with one refill remaining, transferred previously from YNWA Pharmacy.
d. Ativan, at City Pharmacy, a chain with a shared database, written January 27, 2022, filled once with no refills remaining, never transferred.
e. codeine, at a different YNWA Pharmacy, written March 3, 2022, never filled.
a. Librium, at City Pharmacy, a chain with a shared database, written February 18, 2022, filled twice with three refills remaining, transferred previously from another City Pharmacy.
A provider is interested in obtaining a DATA-waived DEA number to treat patients in an office-based treatment program. They are not familiar with the process. Which of the following is an accurate statement the provider should know?
a. The provider may treat 30 patients before obtaining the required DATA-waived DEA number.
b. The provider can prescribe methadone as long as the patient is undergoing short-term detoxification.
c. The provider can only apply for a DATA-waived DEA number if they are a physician.
d. The DATA-waived DEA number must be on every prescription issued for maintenance or detoxification.
e. DATA-waived DEA numbers override regular DEA registrations, and the DATA-waived providers cannot prescribe or treat patients outside of DATA-waived situations.
d. The DATA-waived DEA number must be on every prescription issued for maintenance or detoxification.
A prescriber issued a written prescription for Valium for a patient. There was missing information and errors on the prescription. SELECT ALL OF THE FOLLOWING items a pharmacist could add or change on this prescription based on the actions noted without a prescriber issuing a new prescription.
a. Correct a missing DEA number after discussion with the provider.
b. Change the dose to a lower available dose after discussion with the provider.
c. Add directions when none were listed previously after discussion with the provider.
d. Clarify that we may dispense diazepam for the patient after discussion with the provider.
e. Add an address after consultation with the patient.
all of the above
On January 1, 2022, a provider issued a prescription for four triazolam tablets with one refill. The patient refills the prescription on March 7, 2022. On April 1, 2022, the patient requested additional refills from the prescriber. How many additional refills, if any, may the prescriber authorize on April 1, 2022?
a. 0
b. 3
c. 5
d. 4
e. 1
d. 4
SELECT ALL OF THE FOLLOWING prescriptions that we can accept for Provigil.
a. Electronic prescription electronically signed by the provider.
b. Telephone prescription immediately reduced to writing by the pharmacist receiving the prescription.
c. Faxed prescription manually signed by the provider.
d. Written prescription manually signed by the provider.
all of the above
Vimpat prescription labels must include the no transfer label.
True
False
False
A pharmacy is busy and is running behind in filling prescriptions. The pharmacist decides to send some prescriptions to a central fill pharmacy to alleviate the filling burden. When transmitting a prescription for zolpidem, the pharmacist sent a note saying they did not have time to call the prescriber to correct the prescription information and asked that the central fill pharmacist complete that step. Determine whether the main pharmacy made an error sending the prescription to the central fill pharmacy and, if so, what error the main pharmacy made.
a. This prescription was sent to a central fill pharmacy without being complete, and a central fill pharmacy cannot make corrections to prescriptions.
b. Prescriptions can only be sent to the central fill pharmacy at predetermined times, and they cannot be sent just because the main pharmacy is busy.
c. This prescription is a schedule that can never be filled at a central fill pharmacy.
d. The main pharmacy did not make an error in transmitting this prescription to the central fill pharmacy.
a. This prescription was sent to a central fill pharmacy without being complete, and a central fill pharmacy cannot make corrections to prescriptions.
Which of the following registrations is a valid registration for an institution called Happy Hospital?
a. IH1234564
b. HA1234560
c. MH1234563
d. RH1234567
e. BH1234563
e. BH1234563
A new drug is being put on the market. After reviewing the factors for scheduling, the DEA determines the product should be scheduled. The product has a higher dependence liability than codeine/guaifenesin and lower abuse potential than Xyrem. Which schedule is this product likely to be placed?
a. III
b. IV
c. I
d. V
e. II
b. IV
A pharmacist placed a prescription label on a product. After dispensing, the pharmacist realized that no cautionary statements were included on the prescription label. They are worried they have misbranded the product. Which reason bests describes why this may not be the case?
a. Cautionary statements are minor issues and would not contribute to a patient’s understanding of medication use.
b. Cautionary statements should be provided in the product’s labeling and are not needed on the label.
c. Cautionary statements are not a part of labeling, so this issue is never misbranding.
d. Cautionary statements should be provided verbally to a patient during counseling and are not needed on the label.
e. Cautionary statements are not required on a label unless written on the prescription.
e. Cautionary statements are not required on a label unless written on the prescription.
SELECT ALL OF THE FOLLOWING statements that are true regarding controlled substance distribution.
a. Dispensers may not distribute more than three percent of their total controlled substance dispensing volume
b. Practitioners must always use a DEA 222 when purchasing drugs from a pharmacy.
c. The supplier must ensure the purchaser is registered to handle the controlled substance they ask to purchase.
d. A regular invoice is used when distributing products in schedule III through V.
e. Pharmacies may distribute to other registrants.
c, d, e
SELECT ALL OF THE FOLLOWING items registration is based on.
a. Registration is based on the size of the facility.
b. Registration is based on the amount of drugs handled.
c. Registration is based on the activities a person engages in.
d. Registration is based on the schedules of drugs handled.
e. Registration is based on the location of the facility.
c. Registration is based on the activities a person engages in.
d. Registration is based on the schedules of drugs handled.
A foreign-trained physician issued a prescription using an institutional DEA number and suffix. The physician is a hospitalist and discharged the patient from the hospital today. They prescribed Norco 5/325mg for 14 days to get the patient through until their follow-up appointment with their primary care provider. What is the most appropriate choice and reasoning when considering filling the prescription noted in this situation?
a. Cannot fill, the prescription was issued for a schedule that is not eligible to be prescribed on an institutional DEA number.
b. Can fill, this prescription was issued appropriately.
c. Can fill, it is not a pharmacist’s job to check the legitimacy of institutional DEA use.
d. Cannot fill, foreign-trained physicians cannot use an institutional DEA number.
e. Cannot fill, institutional DEA numbers only authorize providers to prescribe at most a seven-day supply of medication.
b. Can fill, this prescription was issued appropriately.
All of the following drugs can be transferred, except:
a. Lomotil
b. Ultram
c. Restoril
d. Duragesic
e. Subutex
d. Duragesic
Select the best option that differentiates a schedule I product from all other schedules.
a. Schedule I products have very high abuse potential.
b. Schedule I products have no medical use in the US.
c. Schedule I products have a higher risk for dependence liability than products in other schedules.
d. Schedule I products can only be used for research purposes.
e. Schedule I products are the only products used illicitly.
b. Schedule I products have no medical use in the US.
A pharmacy is due to complete its official inventory on April 15, 2022. A non-controlled substance will become a controlled substance on April 14, 2022. What is the most appropriate choice in this case?
a. Count the newly controlled product on the day it becomes controlled and again the next day in the official inventory.
b. Count the newly controlled product on the day it becomes controlled, use that number in the official inventory the next day, and wait to count it again in the next official inventory.
c. Estimate the count on the day the product becomes controlled and exactly count the product the next day with the official inventory.
d. Wait to count the newly controlled product with the official inventory since it is the day after it becomes controlled.
a. Count the newly controlled product on the day it becomes controlled and again the next day in the official inventory.
A student pharmacist was previously convicted of a felony relating to a controlled substance. The board of pharmacy is aware, granted them an intern permit, and required that they notify all rotations sites of the conviction. What is the most likely reason the board noted the student must notify all rotation sites of this issue?
a. The student pharmacist needs to apply for a waiver to have rotations at sites with controlled substance registrations, and the rotation sites must keep a copy of the waiver on file.
b. All rotations sites with controlled substance registrations will need to apply for a waiver to allow the student pharmacist at the site.
c. The student pharmacist should model ethical behavior and share past transgressions openly as an example to others.
d. Notifying rotation sites allows preceptors to challenge the student’s future pharmacist licensure.
b. All rotations sites with controlled substance registrations will need to apply for a waiver to allow the student pharmacist at the site.
SELECT ALL OF THE FOLLOWING appropriate timeframes noted in the Controlled Substance Act.
a. A pharmacy has 60 days from the date written to complete the partial fills for a terminally ill patient.
b. A supplier has 72 hours to complete filling an order for schedule II substances.
c. Records relating to controlled substances must be maintained for two years.
d. Official inventory must be completed at least once a year.
e. A registrant may start maintaining records centrally 14 days after notifying the DEA unless they receive a denial.
a, c, e
A resident on an orthopedic rotation writes a prescription for a patient. The patient is a college friend who called and noted they hurt their knee and were nervous about getting an MRI the next day. The resident decided to prescribe two alprazolam tablets to help with anxiety. They call the pharmacy and leave a voicemail with the prescription. On the voicemail, they leave the hospital’s DEA number and the suffix D01. Which of the following is true?
a. Providers cannot call in prescriptions for friends.
b. This prescription was not issued in the usual course of employment.
c. The indicator, D01, provided with the DEA number, means the resident cannot prescribe more than one pill at a time.
d. This prescription is a schedule that cannot be called in.
e. The prescription may be filled at your pharmacy.
b. This prescription was not issued in the usual course of employment.
A prescriber issued a prescription after the patient paid a high fee to obtain a specific controlled substance. This practice is a red flag that the prescription has not been issued in the usual course of practice or for a legitimate medical use.
True
False
True
